Two phone-based approaches to manage high blood pressure after delivery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized trial compares a high-touch versus a low-touch mobile health strategy for managing postpartum blood pressure among people diagnosed with preeclampsia or gestational hypertension. Eligible participants are enrolled within 14 days of delivery and must have started blood pressure medication before hospital discharge or within 14 days postpartum; they also need to read English or Spanish and have texting capability. Participants are randomized to more intensive remote monitoring and clinician contact or a lower-intensity texting/monitoring program, with outcomes including blood pressure control, measures of cardiac function, and patient-reported engagement and sense of control. The trial is conducted at NYU Langone, The Ohio State University, and the University of Pennsylvania.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥18 years
* Delivery within 14 days
* Diagnosis of preeclampsia or gestational hypertension with or without severe features during pregnancy or within 14 days postpartum
* Initiation of blood pressure medication prior to hospital discharge and up to 14 days postpartum
* English or Spanish speaking (able to read/understand consent and instructions)
* Has phone texting capabilities

Exclusion Criteria:

* Diagnosis of chronic hypertension prior to delivery (would therefore include super imposed preeclampsia)
* Pre-existing cardiovascular disease (including prior myocardial infarction, stroke, heart failure with reduced ejection fraction, ventricular tachycardia, prior cardiac arrest, pacemaker, severe valvular heart disease, or prior cardiac surgery)
* Chronic kidney disease (stage 3 or higher)
* Using ≥3 BP medications at time of enrollment

Where it's running

• NYU Langone Health
  New York, New York, United States Recruiting
• University of Pennsylvania
  Philadelphia, Pennsylvania, United States Recruiting
• The Ohio State University
  Columbus, Ohio, United States Not yet recruiting

Study contacts

• Principal investigator: Jennifer Lewey, MD, MPH — University of Pennsylvania
• Study coordinator: Jennifer Lewey, MD, MPH
• Email: Jennifer.Lewey@pennmedicine.upenn.edu
• Phone: 215-662-7700

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Preeclampsia Biomarker Test in African Women

  This study tests whether measuring the sFlt-1/PlGF ratio using quick clinic tests helps predict which pregnant women in Africa will develop severe preeclampsia.

  Recruiting Africa Clinical Research Network (ACRN) · Harare, Harare · NCT07810439

• Aspirin with or without low‑molecular‑weight heparin to prevent preeclampsia in high‑risk pregnancy

  This trial tests whether adding low‑molecular‑weight heparin (tinzaparin) to low‑dose aspirin reduces the chance of preeclampsia in pregnant people identified as high risk in the first trimester.

  Recruiting Phase 4 Alexandra Hospital, Athens, Greece · Athens, Attica · NCT07361679

• Using low-dose aspirin after preeclampsia to improve recovery

  This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.

  Recruiting Phase 4 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT06281665

• Controlling blood pressure after preeclampsia to improve heart health

  This study is testing if closely managing blood pressure after giving birth can help women who had high blood pressure during pregnancy improve their heart health.

  Recruiting at 2 sites Medical College of Wisconsin · Chicago, Illinois and 1 other locations · NCT06220721

• Improving heart disease prevention after a pregnancy with high blood pressure

  We will test a patient decision aid to help women who had high blood pressure during pregnancy learn about and take steps to prevent heart disease after delivery.

  Recruiting University of Utah · Salt Lake City, Utah · NCT05826925

• Preventing pre-eclampsia with low-dose aspirin in women after frozen embryo transfer

  This study is testing if taking low-dose aspirin can help prevent pre-eclampsia in pregnant women who have had a frozen embryo transfer.

  Recruiting Phase 3 Centre Hospitalier Universitaire de Liege · Liège · NCT05460416

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.